Your browser doesn't support javascript.
Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.
Bhuyan, Prakash; Medin, Jennie; da Silva, Hugo Gomes; Yadavalli, Madhavi; Shankar, Nirmal Kumar; Mullerova, Hana; Arnold, Matthew; Nord, Magnus.
  • Bhuyan P; Global Clinical Development Late R&I, AstraZeneca, Gaithersburg, MD, USA.
  • Medin J; Global Medical BioPharmaceuticals, AstraZeneca, Gothenberg SE431 83, Sweden.
  • da Silva HG; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK.
  • Yadavalli M; Global Patient Safety BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA.
  • Shankar NK; Global Patient Safety BioPharmaceuticals, AstraZeneca, Bangalore, India.
  • Mullerova H; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK.
  • Arnold M; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK.
  • Nord M; Global Patient Safety BioPharmaceuticals, AstraZeneca, Gothenberg SE431 83, Sweden. Electronic address: magnus.nord@astrazeneca.com.
Lancet ; 398(10300): 577-578, 2021 08 14.
Article in English | MEDLINE | ID: covidwho-2184581

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / Global Health / Databases, Factual / COVID-19 Vaccines Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01693-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / Global Health / Databases, Factual / COVID-19 Vaccines Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01693-7